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Edited by Lukas HuberAbstract We have previously reported that the endoplasmic ret-
iculum (ER) stress-regulated transmembrane transcription
factor 6 a (ATF6a) is implicated in the pathogenesis of hepato-
cellular carcinomas (HCCs). In order to further identify genes
that are regulated by ATF6a, the global gene expression proﬁles
of the ATF6a-transfected and untransfected HCC cell line,
HLF, were analyzed. These results were then compared with
the diﬀerential gene expression patterns of poorly diﬀerentiated
HCC and control non-tumorous liver tissue. Our ﬁndings demon-
strate that at least 18 genes are speciﬁcally upregulated by
ATF6a, while another UPR mediator, XBP1 or ER-stress indu-
cer, thapsigargin could partially stimulate or even repress some
of them in HCC cells. Moreover, six of these identiﬁed genes
contain potential ER stress-responsive elements and/or unfolded
protein response elements in their 5 0 regulatory regions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ATF61. Introduction
The endoplasmic reticulum (ER) stress response is a mecha-
nism by which cells respond to the presence of an excess level of
unfolded proteins in the ER. This unfolded protein response
(UPR) has been suggested to contribute to several types of
human disease, including carcinoma [1,2]. Various chemical
and biological stimuli, including hypoxia, also induce ER stress
and initiate the UPR, which is accompanied by the activation
of ER stress transducers such as IRE1, PERK and ATF6.
ATF6, a member of the ATF/CREB family of transcription
factors, has two isoforms of 90-kDa (p90ATF6a) and 110-kDa
(p110ATF6b) as ER transmembrane glycoprotein [3,4]. Upon
ER stress, both p90ATF6a and p110ATF6b are cleaved and
the resulting N-terminal fragments (p50ATF6a and
p60ATF6b) liberated from the ER membrane are translocated
into the nucleus. p50ATF6a binds to the ER stress response*Corresponding author. Fax: +81 4 2996 5190.
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doi:10.1016/j.febslet.2005.11.072element (ERSE) to activate expression of several ER stress-re-
sponse genes including glucose-regulated protein 78 (GRP78)
and glycoprotein 96 (GP96) [5]. However, compared with
p50ATF6a, p60ATFb exhibits much lower speciﬁc transcrip-
tional activity [6].
We have previously identiﬁed GRP78 and GP96 as transfor-
mation-associated genes in hepatocellular carcinoma (HCC)
[7,8]. In addition, our results demonstrated that the ER stress
pathway mediated by ATF6a is essential for the overexpression
of GRP78 in HCC tissue. Although there are several chemicals
and environmental conditions that trigger the activation of
endogenous ATF6a [2,9], the events downstream of such in-
duced-ER stress responses may also involve several unrelated
eﬀects. To further evaluate the eﬀects of ATF6a in HCC, we
overexpressed activated p50ATF6a in a human HCC cell line,
HLF, in which endogenous ATF6 activity is low [7]. We sub-
sequently performed microarray analysis to investigate the po-
tential wide variety of genetic events elicited by ATF6a during
the progression of HCC.2. Materials and methods
2.1. Plasmid construction
A 1.16-kb cDNA insert corresponding to amino acids 1–370 and
encoding activated human ATF6a (GenBank Accession No.:
AB015856); and cDNA inserts corresponding to spliced (activated)
and unspliced XBP1 amino acids (GenBank Accession Nos.:
AB076384 and AB076383), were generated by RT-PCR, as previously
described [10]. The primers used for ampliﬁcation were 5 0-GTC CCA
GAT ATT AAT CAC GGA-3 0 and 5 0-TTA TTT AAG CCT CTG
GTT CTC TGA C-3 0 for ATF6a, and 5 0-CTC GAG CTA TGG
TGG TGG TGG CAG-30 and 5 0-CAT TCC TTA GAC ACT AAT
CAG CTG G-30 for spliced and unspliced XBP1, respectively. The
ampliﬁed cDNAs were cloned into a pcDNA4/TO vector (Invitrogen)
and sequencing examination was performed.
2.2. Tissue specimens, HCC cell lines and transfection experiments
Surgically resected specimens including well-diﬀerentiated, moder-
ately and poorly diﬀerentiated HCCs and adjacent non-cancerous liver
tissues from the same patients were used in this study. All procedures
were performed with the ethical approval of The National Defense
Medical College and informed consent was obtained from each pa-
tient. The human HCC cell line, HLF, was obtained from the Japanese
Collection of Research Biosources (Osaka, Japan) and maintained in
Dulbeccos modiﬁed Eagles minimum essential medium (DMEM),
supplemented with 10% fetal bovine serum (FBS). HLF cells wereblished by Elsevier B.V. All rights reserved.
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reagent (Qiagen) and selected in medium containing zeocin (0.1 mg/
ml; Invitrogen).
2.3. Protein extraction and immunoblotting
Protein extraction and ECL Western blotting analysis (Amersham
Biosciences) were performed using human antiserum (1:300 dilution)
raised against the N-terminal 14 amino acids of ATF6a, as described
previously [7].
2.4. cDNA microarray analysis
cDNA microarray analysis was performed using IntelliGene HS Hu-
man expression chips, containing 16600 probe sets (Takara). Brieﬂy,
4 lg of total RNA was used for double-stranded cDNA probe synthe-
sis with a T7 oligo(dT) primer. Each cDNA fragment was then sub-
jected to RT ampliﬁcation that incorporated aminoallyl-UTP
(Ambion), which was coupled with either Cy3 or Cy5 (Amersham Bio-
sciences). After puriﬁcation through a microcon 30 spin column (Mil-
lipore), the ampliﬁed RNAs were combined and hybridized to the
IntelliGene HS Human expression chips in hybridization buﬀer con-
taining Cot-1 DNA (Invitrogen). Each slide contained duplicate sets
of samples and Cy3/Cy5 labeling of the cDNA probes was reversed
in duplicate experiments. After an overnight hybridization at 70 C,
the slides were washed, scanned for Cy3 and Cy5 ﬂuorescence using
a ScanArray Express microarray reader (Perkin–Elmer), and the signal
was quantiﬁed using ScanArray Express software (Perkin–Elmer).
2.5. Quantitative RT-PCR analysis
To validate the microarray analysis, we performed quantitative RT-
PCR [11] in both the cell lines and the tissue samples. Total RNA iso-
lates (2 lg) were reverse-transcribed using oligo(dT)12–18 primers and
Superscript II (Invitrogen). Oligo primers for RT-PCR were designed
by Primer Express software (Applied Biosystems) and are listed in Ta-
ble 1. Each PCR ampliﬁcation was carried out in triplicate in an ABI
Prism 5700 Sequence Detection System using Sybr Green Mastermix
(Applied Biosystems) for 15 min at 95 C for the initial denaturing, fol-
lowed by 40 cycles of 95 C for 30 s and 60 C for 1 min. The expres-
sion values for each gene were normalized to b2-microglobulin and the
results are displayed as the mean ± S.E. Statistical analysis was per-
formed using the Student t-test.3. Results
3.1. Expression of activated ATF6 in HLF cells
An N-terminal ATF6amutant, lacking both the luminal and
transmembrane domains of the full-length wild-type protein,
encodes the activated form of ATF6a (p50ATF6a, containing
amino acids 1–370), which can spontaneously enter the nucleus
and eﬃciently transactivate UPR-target genes [4]. We transfec-
ted a pcDNA4/TO construct expressing p50ATF6a (Fig. 1A),
into HLF cells, as they contain relatively low levels of endog-
enous ATF6a activity [7]. Two independent p50ATF6a-
expressing clones, designated pATF6a-1 and -2, were obtained
from subsequent stable selection of the transfected cells.
Northern blot analysis revealed that the pATF6a-1 and -2
clones expressed substantial levels of both exogenous trun-
cated ATF6a mRNA (arrow in Fig. 1B) and endogenous
ATF6a mRNA (asterisk).
To examine the expression of p50ATF6a in these stable
transfectants, immunoblotting analysis was performed. As
shown in Fig. 1C, the p50ATF6a protein expression levels cor-
responded to the mRNA levels in these clones (lanes 2 and 3).
Moreover, the addition of the ER-stress inducer, thapsigargin
(TG), caused a dramatic increase in endogenous p50ATF6a in
parental HLF cells (lane 4). Notably, the expression levels of
exogenous p50ATF6a in the pATF6a-1 and -2 clones were sig-
niﬁcantly lower than the TG-induced endogenous p50ATF6alevels in parental HLF cells, but were similar to the innate
expression that is detectable in moderately to poorly diﬀeren-
tiated HCC tissue (lane 6). We thus concluded that the expres-
sion of exogenous p50ATF6a in the stable transfectants was
similar to the physiological expression levels in HCC tissue.
Hence, to evaluate the activity of the exogenous ATF6a gene,
the transcription levels of GRP78, a UPR target gene, were
examined in these transfectants. As shown in Fig. 1B, exoge-
nous ATF6a was found to activate GRP78 in the pATF6a-1
and -2 clones.
3.2. The identiﬁcation of novel genes regulated by ATF6
We demonstrated previously that ATF6a is activated in
poorly diﬀerentiated HCCs [7]. In order to identify additional
genes that are regulated by ATF6a in HLF cells, global gene
expression proﬁles were compared between ATF6a-transfected
and vector-transfected HLF cells using cDNA microarrays.
Total RNA isolates, puriﬁed from either ATF6a-1 and
ATF6a-2 cells or from pcDNA-1 and pcDNA-2 control
HLF cells, were combined for these analyses. Duplicate exper-
iments were performed by interchanging the Cy3/Cy5 labeling
and revealed that 325 genes were upregulated by more than
twofold, whereas 316 genes were downregulated to less than
50% of the controls in the ATF6a transfectants (data not
shown). We then compared the global gene expression proﬁles
in HCC tissues. We performed microarray analyses using
RNA mixtures from three poorly diﬀerentiated HCCs, and
from adjacent non-cancerous liver (NL) tissue controls from
the same patients. We found that 794 and 928 genes were
up- and downregulated in HCC tissues, respectively. Signiﬁ-
cantly, among these diﬀerentially expressed transcripts, 45
and 14 genes were observed to be commonly up- and downreg-
ulated in both ATF6a transfectants and HCCs, compared to
control cells and NL tissues, respectively (data not shown).
PCR analysis using total RNA preparations from the trans-
fected cell lines and from 12 paired HCC and NL tissues fur-
ther demonstrated that 18 of the upregulated gene are
signiﬁcantly overexpressed in ATF6a transfectants and HCCs
compared to the transfection control cells and the NL tissues
(Table 1). The high levels of activation of these genes among
the 12 HCC tissues are shown in Fig. 2. Overexpression levels
of these mRNAs among HCC tissues varied from 1.6-fold
(PRDX2) to 27.9-fold (HMMR), respectively. Notably, the
expression of PDIA4, GP96, GRP78, PRDX2, RAN, SRR,
HMMR and UNC13B seemed to be preferentially elevated in
poorly diﬀerentiated HCCs than in other tumors. In contrast,
however, none of the downregulated genes identiﬁed in the
ATF6a transfectants were found to be signiﬁcantly suppressed
in HCC over NL tissues (data not shown).
3.3. Regulation of ATF6-inducible genes by XBP1
It has been reported that signaling systems including ATF6
and IRE1 operate UPR target genes including chaperones [2].
A role of IRE1 in the UPR is to convert unspliced XBP1
mRNA to the spliced form that encodes an active XBP1 prod-
uct [2]. We have demonstrated that not only ATF6 but also
XBP1 transcripts are activated in poorly diﬀerentiated HCC
tissues [7]. Therefore, in order to examine the eﬀects of
XBP1 upon the expression of the 18 upregulated genes above
mentioned, we transfected pcDNA4/TOs harboring spliced
(encoding activated form; denoted as –S–) and, as a control,
unspliced (unactivated form; denoted as –U–) XBP1 cDNAs
Table 1
Commonly upregulated genes in both ATF6a-transfected HLF cells and HCC tissues
Symbol GenBank
Accession No.
Gene name HCC/NL
ratioa
ATF6a/vector
ratiob
XBP1-s/-u ratioc TGh+/ PCR primers (forward/reverse)
Chaperone
PDIA4 NM_004911 Protein disulﬁde isomerase
associated 4
2.85 ± 0.4e 11.29 ± 4.48 2.19 ± 0.26 4.60 CACCAGAAGTCACGCTTGTGTTGA/AGGAGAACGCTTGCTGAGCTCCTT
GP96 NM_003299 Glycoprotein 96 2.46 ± 0.39e 4.20 ± 0.72 2.34 ± 0.34 4.20 CAGAATGTTGCCAAGGAAGGAGTG/AAAGCACACGGAGATTCTGTCAGG
DNAJB11 NM_016306 DnaJ (Hsp40) homolog,
subfamily B, member 11
2.75 ± 0.38d 7.13 ± 3.01 2.16 ± 01.2 4.70 TGCCTGTTGCTGCTATACCTCATC/AACCTCATAAGCAGCACCCAGATC
GRP78 NM_005347 Glucose-related protein 78 2.63 ± 0.58g 4.24 ± 1.70 1.74 ± 0.09 13.82 TGGAATCTTCACCTCAGAGTGGAG/CAGATGCACATGACCCAGTTGTTA
Cell cycle/proliferation
BUB1 NM_004336 Budding uninhibited by
benzimidazoles 1 homolog
(yeast)
9.13 ± 3.12g 5.08 ± 1.31 1.19 ± 0.95 0.63 AGGACCTTTGGAGAACGCTCTGTC/ATGGTGTAGACGCAAGTTGTGCAG
CDKN3 NM_005192 Cyclin-dependent kinase
inhibitor 3
9.50 ± 2.26e 2.78 ± 0.76 1.36 ± 1.08 0.45 CTTCTGGATCTCTACCAGCAATGTGG/ACAAGACAAGATCTCCCAAGTCCTCC
STK6 NM_003600 Serine/threonine kinase 6 4.94 ± 1.37e 3.79 ± 1.25 1.42 ± 1.10 0.45 GCTGCCCTCAATCTAGAACGCTACAC/GTCGAACCTTGCCTCCAGATTATGAA
FDPS NM_002004 Farnesyl diphosphate
synthase
3.11 ± 0.68e 4.62 ± 0.76 1.32 ± 0.45 1.15 ACATCCAGGACAACAAATGCAGCT/CATATTGCAAGAACACTGCTGGCA
UBE2C NM_007019 Ubiquitin-conjugating
enzyme E2C
9.10 ± 2.85g 3.19 ± 1.26 1.04 ± 0.56 0.69 ACGTGGACACCCAGGGTAACATAT/TGCTTTGAGTAGGTTTCTTGCAGG
PRDX2 NM_005809 Peroxiredoxin 2 1.60 ± 0.32g 12.14 ± 10.35 1.08 ± 2.04 0.01 GTCCTTCGCCAGATCACTGTTAATG/CCGTTAGCCAGCCTAATTGTGTTT
RAN NM_006325 RAN, member RAS
oncogene family
2.61 ± 0.49f 2.15 ± 0.46 1.001 ± 0.74 0.55 ATTGGTTGGTGATGGTGGTACTGG/CGGCTGTGTCCCATACATTGAACT
SRR NM_021947 Serine racemase 2.06 ± 0.43S 2.49 ± 0.78 1.27 ± 0.55 0.67 ATCCACCTCACACCAGTGCTAACA/TGTGAGTAACAACAGCTTTCGGCT
Signal transduction
HMMR NM_012484 Hyaluronan-mediated
motility receptor,
transcript variant 1
27.94 ± 11.11f 4.22 ± 0.53 1.11 ± 0.51 0.65 TGTTGAATGAACATGGTGCAGCTC/TAGCAAGCTGACAGCGGAGTTTTG
NUCB2 NM_0050I3 Nucleobindin 2 4.03 ± 1.13e 4.65 ± 1.01 4.06 ± 1.39 2.35 GGCCAGAACGTGTTACGAGTCAGT/CTCCACCTCATGTTCAGGCAGGTA
ON NM_003118 Osteonectin 3.55 ± 0.84f 4.24 ± 1.33 3.97 ± 0.53 0.52 ACGGACTGTCAGTTCTCTGGGAAG/AACAACCGATTCACCAACTCCACT
Apoptosis
UNC13B NM_006377 Unc-13-like (C. elegans) 3.60 ± 0.74g 3.22 ± 1.24 1.06 ± 1.60 0.71 CATAACTTTGAGGTCTGGACGGCC/GGCAGTCAGCATTGAGCAGATCCT
Transport
UGTrell NM_005827 UDP-galactose
transportor related
isozymes 1
1.85 ± 0.25e 2. 01 ± 0.34 1.52 ± 0.36 2.75 GGCCAAGTACCTGTGTGTGCTGTT/AACACCAGTCAGTCCATCCAGGGT
Cell adhesion
TROAP NM_005480 Trophinin associated
protein
12.85 ± 3.11f 5.50 ± 1.55 0.85 ± 0.89 1.00 TTCCAGGAGCTAAGAAGGGAGACA/CCTCCTTCATCTGAGTGAGTGACAA
Changes in the expression level were independently tested using quantitative RT-PCR analysis of RNAs from HCC and NL tissues, or ATF6a transfectants and control cells.
aThe results are shown by means ± S.E. (n = 12).
bMean ± range (n = 2).
cMean ± S.D. (n = 3).
dP < 0.001.
eP < 0.005.
fP < 0.01.
gP < 0.05.
hFold induction by TG after 12 h (see Fig. 4).
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Fig. 1. (A) The pcDNA4/TO vector harboring p50ATF6a, the
activated form of ATF6a (containing amino acids 1–370). Sites of
the basic region, leucine zipper (LZ) and transmembrane domain (TM)
are indicated. (B) Northern blot analysis of ATF6a transfectants and
control cells. Identical membranes were successively hybridized with
ATF6a and GRP78 probes. Exogenous truncated ATF6a mRNA
(arrow) and endogenous full length ATF6a mRNA (asterisk) are
indicated. As a loading control, 18S ribosomal RNA stained with
ethidium bromide (EtBr) is shown. (C) Immunoblotting analysis of the
p50ATF6a in ATF6a-transfected HLF cells. Cell lysates were prepared
from control cells (lane 1) and ATF6a transfectants (lanes 2 and 3).
Tissue extracts were prepared from non-cancerous liver (lane 5) and
from moderately to poorly diﬀerentiated HCC tissues (lane 6). As a
positive control, HLF cells were treated with 300 nM of thapsigargin
(TG) for 8 h in DMEM supplemented with 10% FBS (lane 4). The
positions of the 90 and 50 kDa ATF6a species are indicated by arrows.
10 lg of each protein sample was loaded.
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ing XBP1-S transcripts, and three clones expressing XBP1-U
transcripts were established, respectively. As shown in Fig. 3,
pXBP1-S-transfectants and TG-treated cells expressed both
endogenous unspliced (442 bp; referred to U) and exogenous
or endogenously spliced (416 bp; referred to S) XBP1 tran-
scripts (lanes 2–4 and 7), while pXBP1-U-transfectants as well
as vector-transfected cells expressed only the unspliced form
(lanes 1, 5–7). To analyze mRNA levels of the 18 upregulated
genes in these cells, quantitative RT-PCR was performed, andthe average ratios of pXBP1-S-cells/pXBP1-U-cells (XBP1-S/-
U) relative to that of b2M were calculated. In XBP1-S-trans-
fectants, the expression of chaperones (PDIA4, GP96,
DNAJB11 and GRP78) and some signal transduction-associ-
ated genes (NUCB2 and ON) was signiﬁcantly upregulated
(Table 1). However, genes associated with cell cycle/prolifera-
tion, apoptosis, transport and cell adhesion seemed to be unaf-
fected by XBP1-S in HLF cells.
3.4. Eﬀect of ER-stress inducer, thapsigargin upon
ATF6-inducible genes
Since the eﬀects of ER-stress inducers, like as TG can be, in
part, mediated by ATF6 and/or XBP1 systems [2], the expres-
sion of the 18 upregulated genes was examined in TG-treated
HLF cells. Total RNAs were isolated from HLF cells treated
with 100 nM of TG for 3, 6, and 12 h, respectively. As shown
in Fig. 4 and Table 1, the expression of chaperon genes (PDIA4,
GP96,DNAJB11 andGRP78),NUCB2 andUGTrel1was time-
dependently elevated after 3, 6 and 12 h of TG treatment. Unex-
pectedly, the expression of most cell cycle/proliferation-associ-
ated genes (BUB1, CDKN3, STK6, UBEC2, PRDX2, RAN
and SRR), signal transduction-associated genes (HMMR and
ON) and UNC13B was rather suppressed in TG-treated cells.
3.5. The existence of putative ER-stress response and/or
unfolded protein response elements within the promoter
regions of ATF6a-regulated genes in HCC cells
We next performed sequence analysis of the promoter re-
gions of the 18 putatively upregulated genes in HCC. The re-
sults of these analyses showed that in 8 cases, including
GRP78 and GP96, the promoter regions contained sequences
that perfectly matched, or very closely resembled, three
ATF6 response elements; the ERSE I and II and the UPR ele-
ment (UPRE). The putative responsive elements in the pro-
moters of 6 of these newly identiﬁed genes are shown in
Table 2. The presence of such sites in the promoter regions
strongly suggests that p50ATF6a may directly activate these
genes via cis-acting regulatory elements.4. Discussion
We have previously reported that p50ATF6a is speciﬁcally
activated in poorly diﬀerentiated HCCs [7]. To further evaluate
genes whose expression is regulated by ATF6a during the pro-
cess of hepatocarcinogenesis, gene expression proﬁles were
compared between ATF6a transfected- and untransfected-
HLF cells, and between HCC and NL tissues, using cDNA
microarrays. We eventually focused on the expression of 18
genes, including GRP78 and GP96, whose expression is signif-
icantly elevated not only in ATF6a transfected HLF cells but
also in HCC tissues. Most ATF6a upregulated genes had been
known as ER-resident proteins like as chaperones [9]. Here we
report that ATF6a could also activate the expression of cell cy-
cle/proliferation-associated and other functional genes, which
are also activated in HCC tissues. However, the ER-stress in-
ducer, TG or the UPR mediator, XBP1 could only partially or
even negatively aﬀect upon the expression of some of the
ATF6-activating genes in HCC cells (Fig. 4 and Table 1).
Therefore, the ATF6-dependent activation of these genes in
hepatocarcinogenesis may not simply be the results of UPR.
Fig. 2. HCC/non-cancerous liver (NL) ratios of mRNA levels. The relative expression levels were calculated against the levels of b2-microglobulin
expression. A paired t test was performed to ascertain the statistical signiﬁcance between expression levels in both tissue sets. Empty circles denote
well to moderately, and ﬁlled circles denote poorly diﬀerentiated HCC tissues, respectively. The mean HCC/NL ratio is shown (——).
Fig. 3. Expression of spliced (S) and unspliced (U) XBP1 transcripts in
XBP1-S- and XBP1-U-transfected HLF cells. RT-PCR analysis was
performed using total RNA from control cells (lane 1), pXBP1-S-1, -2,
-3 (lanes 2, 3 and 4) and pXBP1-U-1, -2, -3 (lanes 5, 6 and 7) cells.
Spliced (S; 416 bp) and unspliced (U; 422 bp) XBP1 transcripts are
indicated. As a positive control, HLF cells were treated with 300 nM of
thapsigargin (TG) (lane 8). b2-Microgrobulin was used as an internal
control.
Fig. 4. The eﬀects of thapsigargin on the expression of 18 upregulated
genes. HLF cells were cultured in the presence of thapsigargin
(100 nM). For quantitative RT-PCR analysis, total RNA was
extracted at indicated time points (h). b2-Microgrobulin was used as
an internal control.
188 M. Arai et al. / FEBS Letters 580 (2006) 184–190The reason for downregulation of many genes during TG
treatment (Fig. 4 and Table 1) is currently unclear. Our obser-
vation demonstrated that the genes upregulated by TG could
also be activated by ATF6a and XBP1-S, respectively. Interest-
ingly, most downregulated genes by TG seemed to be unrespon-
sive to XBP1-S. Therefore, the transcriptional suppression by
TG may occur in response to XBP1 function via yet unknown
mechanisms.
Among these 18 genes, six newly identiﬁed genes were found
to carry potential ATF6 response elements, including ERSE I,ERSE II and/or UPRE, in their promoter regions (see Table
2). This ﬁnding strongly suggests that these genes can be
directly regulated by ATF6 via cis-acting elements. PDIA4,
also known as Erp72 harbors core regulatory sites sensitive
to ER stress in the 5 0 franking region [12]. This includes
CCAAT elements, to which the general transcription factor,
NF-Y binds [13], however no consensus p50ATF6a site was
identiﬁed close to the NF-Y sites in these areas (not shown).
Table 2
Presence of ERSE-I, ERSE-II, and UPRE in the upstream regulatory regions of ATF6a-regulated genes in the HCC cells
ERSE-I CCAAT-N9-CCACG ERSE-II ATTGG-N-CCACG UPRE TGACGTGG/A
UBE2C 1068 CCAACCTGGGAGCACCATG 1050 95 AGTGGCGCAGC 85 1369 TCACGTGG 1362
127 CCAATAGCGGTGCGCCAGT 109 30 ATTGGTCGACG 20
STK6 297 CCAATCTACCGCTCCGAGC 279 128 TGACGTCA 120
CDKN3 354 CCAACCGTATGGACCACG 337
BUB1 842 CCAAGGACACTAACCCATC 824
274 CCAATTCCCTACGCCCGAGC 255
UGTrell 333 CCAATTGGTGGCCTCCACA 315
SRR 934 TGACGTGG 927
Sequences of the regulatory regions of ERSE-I, ERSE-II, and UPRE are shown. The putative consensus sequence is boldface. Numbers denote
nucleotide positions, with respective transcription start site set at 1.
M. Arai et al. / FEBS Letters 580 (2006) 184–190 189DnaJ (Hsp40) family also harbor NF-Y binding elements in
their promoter region [14]. Interestingly, our results demon-
strated that the expression of PDIA4 and DNAJB11 was
markedly stimulated by ATF6a in HLF cells. Therefore, there
may be unidentiﬁed ATF6a interacting sequence, other than
the conventional ATF6a binding sites, in their regulatory re-
gions. Or, like other genes that are upregulated by ATF6a,
the activation would likely occur indirectly through one or
more intermediary molecules.
Among the upregulated genes harboring potential ATF6a-
response elements, ubiquitin-conjugating enzyme E2C
(UBE2C), serine/threonine kinase 6 (STK6), cyclin-dependent
kinase inhibitor 3 (CDKN3) and budding uninhibited by benz-
imidazoles 1 homolog (BUB1) are known to essential for the
regulation of the cell cycle, cellular proliferation and mitosis
[15–17]. Serine racemase (SRR) converts L-serine to D-serine,
which is involved in cell migration [18]. In addition, the
UDP-galactose transporter related isozyme 1 gene (UGTrel1)
plays a role in membrane transport [19].
UBE2C has been identiﬁed previously as a human homolog
of cyclin-selective E2 (E2-C), a gene that is required for the
destruction of mitotic cyclins [17]. Moreover, UBE2C has been
shown to be overexpressed in wide variety of carcinomas [20]
and cause accelerated growth rate, higher saturation density
and promote anchorage-independent growth [21]. Further-
more, a dominant-negative UBE2C arrests mammalian cells
in M phase and inhibits the onset of anaphase [17], and siRNA
molecules that target UBE2C increase the sensitivity of neo-
plastic cells to TRAIL/DR5-induced cell death [20]. These pre-
vious ﬁndings suggest that activation of UBE2C by ATF6a
may be associated with hepatocarcinogenesis.
The results presented in our current study demonstrate that
ATF6a has additional global eﬀects in HCC cells by directly
and indirectly regulating the expression of a large number of
genes. Future studies focused on the regulation and functional
signiﬁcance of the target genes reported here should therefore
increase our knowledge of the biological activity of ATF6a in
both neoplastic and non-neoplastic cells.References
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